Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19
Clinical trial NCT04423861 · UNKNOWN
Trial details
- NCT number
- NCT04423861
- Sponsor
- Azidus Brasil
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-22
- Primary completion
- 2023-03-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.